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Previous studies have shown that in a given cell type, certain active genes associate with SC-35 domains, nuclear regions
rich in RNA metabolic factors and excluded from heterochromatin. This organization is not seen for all active genes;
therefore, it is important to determine whether and when this locus-specific organization arises during development and
differentiation of specific cell types. Here, we investigate whether gene organization relative to SC-35 domains is cell type
specific by following several muscle and nonmuscle genes in human fibroblasts, committed but proliferative myoblasts,
and terminally differentiated muscle. Although no change was seen for other loci, two muscle genes (Human -cardiac
myosin heavy chain and myogenin) became localized to the periphery of an SC-35 domain in terminally differentiated
muscle nuclei, but not in proliferative myoblasts or in fibroblasts. There was no apparent change in gene localization
relative to either the chromosome territory or the heterochromatic compartment; thus, the gene repositioning seemed to
occur specifically with respect to SC-35 domains. This gene relocation adjacent to a prominent SC-35 domain was
recapitulated in mouse 3T3 cells induced into myogenesis by introduction of MyoD. Results demonstrate a cell type-
specific reorganization of specific developmentally regulated loci relative to large domains of RNA metabolic factors,
which may facilitate developmental regulation of genome expression.
INTRODUCTION
Formation of distinct cell types during the development of
higher organisms requires the orchestrated expression of
40,000 genes. Cells become progressively more restricted
in developmental potential as they commit to specific lin-
eages, with the result that only a small subset of genes is
fully competent to be expressed in subsequent cell genera-
tions. Concomitant with this genome-wide epigenetic regu-
lation are overall changes in the morphology and internal
appearance of the cell nucleus, as exemplified by the cell
type-specific arrangement of heterochromatin and of nucle-
oli (Comings, 1968; Manuelidis, 1984; Carter et al., 1991;
Cremer and Cremer, 2001). The known clustering of gene-
rich DNA into metaphase chromosome bands provides ev-
idence of some higher order organization of the genome
(Bickmore and Sumner, 1989; Saitoh and Laemmli, 1994).
These and other observations have contributed to long-
standing speculation that there may be a cell type-specific
organization of genes in interphase nuclei that facilitates cell
type-specific gene expression. Higher order organization
may impact a gene’s relationship to other intranuclear struc-
tures: for example, genes may have specific spatial arrange-
ments relative to domains enriched in RNA metabolic fac-
tors (Xing et al., 1993; Xing et al., 1995; Smith et al., 1999),
relative to the interphase chromosome territory and inter-
chromosomal regions (Clemson et al., 1996; Kurz et al., 1996;
Cremer and Cremer, 2001; reviewed in Mahy et al., 2002), or
relative to heterochromatin (Xing et al., 1995; Brown et al.,
1997; reviewed in Gasser, 2001).
The primary focus of this study is to compare the organi-
zation of specific genes relative to SC-35–enriched domains
in the context of myoblast differentiation. SC-35 domains are
subnuclear compartments rich in poly A RNA (Carter et al.,
1991; Visa et al., 1993) and certain mRNAs (Shopland et al.,
2002), as well as a variety of RNA metabolic factors, includ-
ing spliceosome assembly factor SC-35 (Fu and Maniatis,
1990; Blencowe et al., 1994), numerous other splicing factors
(Nyman et al., 1986; Spector et al., 1991), a subset of poly (A)
polymerase (Schul et al., 1998), a putative RNA helicase (Gee
et al., 1997), and a hyperphosphorylated form of RNA poly-
merase II (Bregman et al., 1995). These 20–40 globular do-
mains consist of the more prominent (0.5–3 m in diameter)
components of the small nuclear ribonucleoprotein “speck-
led” staining pattern and occupy 5% of the nuclear vol-
ume, lying in a narrow focal plane in cultured human fibro-
blasts and myoblasts (Carter et al., 1993).
Quantitative analyses have shown that SC-35 domains
have statistically highly significant associations with certain
active genes and their transcripts (Xing et al., 1995; Smith et
al., 1999). To date, of the multiple active genes examined this
way, more than half have been shown to be highly (70–
100%) associated with SC-35 domains, whereas inactive
genes show only low (10–20%) apparent association.
Clearly, the distribution of individual genes or pre-mRNAs
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relative to these domains is not random, but gene specific,
with associated genes consistently positioning at the domain
edge. Several inactive genes studied were frequently at the
nuclear periphery, a region devoid of SC-35 domains and
enriched with heterochromatin (Xing et al., 1995; Smith et al.,
1999). These findings suggest the fundamental hypothesis of
a cell type-specific genomic organization that provides
many active genes immediate access to copious supplies of
RNA metabolic factors within “domains,” potentially facil-
itating expression of those genes.
Although indirect evidence suggests that association with
SC-35 domains is related to gene expression, the relationship
is not simple. For example, some genes producing highly
spliced pre-mRNAs essentially never associate (Smith et al.,
1999), and even genes that associate with high frequency are
not always associated with a domain even while still clearly
expressing pre-mRNA (Xing et al., 1993, 1995). Other work
has shown that an intronless heat-shock gene associates with
SC-35 domains upon heat shock, indicating that the associ-
ation is not always related to splicing but may be related to
transcription (Jolly et al., 1999). Although a relationship of
this gene arrangement to cell type is implicated by some
observations, to establish this key point requires a system-
atic analysis of several active and inactive genes relative to
SC-35 domains in different cell types of a developmental
system. Hence, it is important to track potential changes in
the spatial relationship with SC-35 domains of several loci as
they progress through developmental transitions and states
of expression. Furthermore, it would be valuable to include
analysis of one or more genes that are not particularly highly
expressed and complex, to discriminate between changes in
gene organization relative to SC-35 domains and the accu-
mulation of factors on abundant nuclear RNA of a single
gene.
To address the hypothesis that higher order organization
of genes relative to SC-35 domains changes with develop-
ment and cell type-specific gene expression, we investigated
this for seven endogenous loci, including three muscle-spe-
cific genes, during in vitro skeletal muscle differentiation.
Because changes in gene organization might occur concom-
itant with cell-type commitment, but before gene expression
in a fully differentiated cell, we compared organization of
several genes in differentiated muscle cells with that of both
fibroblasts and committed but undifferentiated myoblasts.
To further establish that observed changes in organization of
specific genes with SC-35 domains was related to cell-type
changes during myogenesis, we tested whether this reorga-
nization could be recapitulated in mouse 3T3 cells induced
to form muscle by introduction of MyoD. Finally, we briefly
examined changes in gene organization with SC-35 domains
in the context of other potential organizational changes,
specifically the placement within the chromosome territory
and localization relative to centric heterochromatin.
MATERIALS AND METHODS
Cell Culture and In Vitro Myogenic Differentiation
Normal human fibroblast cells (Detroit 551 or WI-38; American Type Culture
Collection, Manassas, VA) were used as nonmyogenic cell controls, and were
cultured as described previously (Xing et al., 1995). Flow-sorted undifferen-
tiated normal human myoblast cells (strain 50Mb-1), isolated from the vastus
lateralis muscle of a 10-year-old male, were kindly provided by Dr. Helen
Blau (Stanford University, Palo Alto, CA) (Webster et al., 1988; Smith et al.,
1999). Proliferative myoblast cells were cultured in growth media (GM)
comprised of Ham’s F-10 media supplemented with 20% fetal bovine serum
(Hyclone Laboratories, Logan, UT), 1% (vol/vol) chick embryo extract (60-Å
ultrafiltrate), with penicillin and streptomycin, and seeded onto glass cover-
slips (Corning Glassworks, Corning, NY). In vitro myogenic differentiation
was induced by culturing myoblasts in GM to 70% confluence, and then
switching to low serum differentiation media (DM; DMEM-low glucose sup-
plemented with 2% horse serum (Hyclone Laboratories), 1 mM insulin, 1 mM
dexamethasone (Sigma-Aldrich), 100 U/ml penicillin and 100 g/ml strep-
tomycin). Multinucleated myofibers typically were first noted on day 3, and
differentiation was typically complete by day 7. Cell processing for in situ
hybridization, involving detergent permeabilization and paraformaldehyde
fixation, was as described previously (Xing et al., 1995).
A second cell differentiation model utilized mouse NIH3T3-derived cells
(B22 cells) that had been induced to form myoblasts using a MyoD-expressing
retrovirus, as previously described (Novitch et al., 1996). Cultures at 50%
confluency were infected for 30 h with one-third of the supernatant from a
confluent 100-mm plate of BOSC23 cells generating MyoD retrovirus and
polybrene (4 g/ml) diluted into fresh media. Mock-infected plates were
exposed to media and polybrene only. Differentiation was induced by growth
in low serum medium for 36 h or more (Novitch et al., 1996).
The B22 cell line expresses dominant-negative BRG1 protein under the
control of the tet promoter (de La Serna et al., 2000). For analysis of normal
cells, B22 cells were grown in tetracycline, which represses expression of the
mutant protein. To prevent myogenic gene expression, cells were grown
without tetracycline, which allows expression of mutant BRG1. The domi-
nant-negative BRG1 is ATPase deficient and forms dominant-negative SWI/
SNF complexes that interfere with MyoD-induced differentiation (de La Serna
et al., 2001a)
Hybridization Probes and Immunofluorescence Reagents
Human -cardiac myosin heavy chain (MyHC) was detected using a 12.3-kb
clone (p8-1A) from L. Leinwand (University of Colorado, Boulder, CO) (Liew
et al., 1990) encompassing the intergenic spacer and extending partly into the
5 region of the closely linked -gene. The closely linked - and -genes are
highly homologous, but only  is expressed in cultured muscle (Yamauchi-
Takihara et al., 1989). We used a 30-kb cosmid clone containing the entire
MyoD gene (cHMD-13) and 5-upstream sequences (Goldhamer et al., 1992)
from C. Emerson (University of Pennsylvania Medical Center, Philadelphia,
PA). Human myogenin (myf-4) was detected using a 5.8-kb plasmid clone
containing the entire human gene (Braun et al., 1989), supplied by H. Arnold
(Technische Universita¨t Braunschweig, Braunschweig, Germany). Mouse
myogenin (Edmondson et al., 1992) was detected with a 16-kb genomic probe
from D. Edmondson and E. Olson (University of Texas, M.D. Anderson
Cancer Center, Houston, TX). Nonmyogenic sequences used were described
previously (Xing et al., 1995). Whole chromosome 14 was detected using a
digoxigenin-labeled Coatasome total chromosome probe (Oncor, Gaithers-
burg, MD).
A mouse monoclonal antibody against the SR (arginine/serine) spliceo-
some assembly protein SC-35 (Fu and Maniatis, 1990) was obtained from
X.-D. Fu (University of California, San Diego, San Diego, CA) or Sigma-
Aldrich (St. Louis, MO). SRM300, a 300-kDa SR-related nuclear matrix antigen
used to detect SC-35 domains in mouse cells was provided by Dr. B.J.
Blencowe (University of Toronto, Toronto, ON, Canada). Mouse anti-myoge-
nin was purchased from BD PharMingen (San Diego, CA) and rabbit poly-
clonal IgG anti-MyoD was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA).
Fluorescence In Situ Hybridization
Methods used here have been published in detail elsewhere (Carter et al.,
1991; Johnson et al., 1991; Tam et al., 2002). In brief, DNA probes were nick
translated with either biotin-11-dUTP or digoxigenin-16-dUTP (Roche Diag-
nostics, Indianapolis, IN). DNA-specific hybridization was accomplished by
simultaneously hydrolyzing nuclear RNAs and denaturing target DNAs in
0.07 N NaOH for 5 min, followed by application of probe. RNA-specific
hybridization involved applying probe to nondenatured cells such that cel-
lular DNA is not available for hybridization. Cells subjected to immunoflu-
orescence analysis after hybridization were fixed for 10 min before application
of antibody. Total nuclear DNA was stained using 1 g/ml 4,6-diamidino-2-
phenylindole (DAPI) for 30 s, which in mouse preferentially stains the A-T–
rich DNA present in all mouse centromeric heterochromatin. The chromo-
some 14 interphase territory was painted, as described previously (Clemson
et al., 1996). Cells were permeabilized with 0.5% Triton X-100 for 7 min before
a heat denaturation in 70% formamide, 2  SSC at 85°C for 5 min. Ten
microliters of whole chromosome paint, denatured for 5 min at 75°C and
prehybridized at 37°C for 2 h, was applied to dehydrated cells, and hybrid-
ized overnight. The painting probe was detected using rhodamine antidigoxi-
genin antibody (Roche Diagnostics).
Microscopy and Analysis
An Axioplan microscope (Carl Zeiss, Thornwood, NY) designed for imaging
multicolor fluorescence was used. Variable excitation using a filter wheel
(Ludl Electronic Products, Hawthorne, NY) in conjunction with multiband-
pass emission filters (Chroma Technology, Brattleboro, VT) was used for two
or three color in-register imaging. High-resolution digital image capture was
performed using a Photometrics 200 Series camera (Photometrics, Tucson,
AZ), a high-resolution, low-depth of field objective (100, numerical aperture
1.4; Carl Zeiss), and image acquisition and analysis software (GW Hannaway
P.T. Moen et al.
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and Associates, Boulder, CO; and MetaMorph, Universal Imaging, Dowing-
town, PA).
Signal was scored as associated with an SC-35 domain when there was no
visible separation between the signal and the SC35 domain boundary. Signal
was occasionally associated with small concentrations of SC-35 (0.5 m), but
this was not scored as associated with a domain unless a large (typically 0.5–3
m) prominent domain was present. All experiments were viewed and, when
possible, analyzed directly through the microscope. Data represents multiple
experiments analyzed independently by at least two investigators. For anal-
ysis of association with the peripheral heterochromatin, gene signals were
scored as associated if they were in contact with or very close (0.6 m) to the
edge of the nucleus.
RESULTS
Localization of Muscle-specific and Nonmuscle-specific
Sequences in Myotube Nuclei
Before comparing the distribution of genes in different cell
types, we first examined the distribution of seven different
sequences, including muscle and nonmuscle genes, in fully
differentiated human skeletal muscle, by using fluorescence
in situ hybridization to detect specific nuclear RNAs and/or
the corresponding gene (see MATERIALS AND METH-
ODS). In 98% of the postmitotic nuclei within multinucle-
ated skeletal myotubes, the RNA accumulations from the
-cardiac myosin heavy chain genes (cMyHC) associate with
SC-35 domains. As described in MATERIALS AND METH-
ODS, any signal that seemed to contact the domain with no
visible separation is scored as “associated,” whereas even a
slight visible separation is considered nonassociated. Typi-
cally, both of these slightly elongated accumulations overlap
much of the domain (Figure 1, A and C), as described
previously and termed a “type I” RNA pattern (Smith et al.,
1999). The cMyHC gene, in contrast, consistently localizes
immediately adjacent to or partially overlapping the edge of
the SC-35 domain, similar to COL1A1 gene and its nuclear
RNA (Xing et al., 1995).
The positions of two other muscle-specific genes, myoge-
nin (myf-4) and MyoD, were also examined in differentiated
myofibers. Human myogenin and MyoD are muscle regula-
tory proteins that are expressed at similar levels from genes
of similar size and complexity, both of which are less com-
plex and less highly expressed than cMyHC (Braun et al.,
1990; Goldhamer et al., 1992). In contrast to the more glob-
ular or track-like morphology of cMyHC RNA, myogenin
and MyoD nuclear RNAs produced two small bright foci
(Figure 1, B, D, and G), similar to the round hybridization
spots from a single copy gene. For200 myogenin RNA foci
examined, 88% were associated with a prominent (0.5–3.0
m in diameter) SC-35 domain (Figure 1, B and D). The
domain was much larger than the round spot of RNA signal,
which contacted or slightly overlapped the domain periph-
ery but did not occupy its central regions. This RNA distri-
bution pattern has been termed “type II” (Smith et al., 1999).
Because the RNA foci are smaller and at the edge of the
domain, the domain clearly represents a distinct entity, a
large accumulation of factors with which the gene and its
RNA associates. Hybridization to myogenin DNA yielded
results comparable with the RNA, with the gene also local-
izing to the domain periphery (Figure 1E). Note that in some
nuclei both alleles associated with the same domain (Figure
1, E and F), supporting the idea that multiple genes cluster
at these structures, as further demonstrated in Shopland et
al. (2003).
In the same experiments, the MyoD RNA foci, virtually
indistinguishable in size and intensity to myogenin RNA
foci, did not associate with prominent splicing factor do-
mains in the majority of myotube nuclei (Figure 1G, inset).
In some experiments, MyoD RNA was associated with very
small concentrations of SC-35, but only infrequently (12%)
seemed to contact one of the 20–40 prominent (0.5–3.0 m)
SC-35 domains. These low rates of apparent association are
in keeping with that expected for a “random” distribution
within the limits of our analytical approach (Xing et al.,
1995). Similar to its nuclear RNA, only 12% of MyoD DNA
signals associated with SC-35 domains (Figure 1H). Hence,
despite close similarities in the size of their genes and nu-
clear RNA accumulations, the myogenin gene is expressed
at the periphery of a large domain of RNA metabolic factors,
whereas the MyoD gene is not. These results support our
earlier suggestion that genes are expressed in different nu-
clear environments, and are consistent with previous evi-
dence that there are sufficient splicing factors in the interdo-
main space to process even highly complex pre-mRNAs
(Smith et al., 1999).
For comparison to a broader view of sequence localization
relative to SC-35 in muscle nuclei, we examined other non-
myogenic sequences in differentiated myotube nuclei, in-
cluding sequences that are not expressed or do not encode
pre-mRNA. As summarized in Figure 2, hybridization to the
RNA polymerase III transcribed gene for human 5S rRNA
(Little and Braaten, 1989) indicated only infrequent associa-
tion with SC-35 domains. Similarly, the transcriptionally
inactive human albumin gene (HSA-10; ATCC) (Figure 2),
and a chromosome 17 alphoid repeat sequence, p3.6 (our
unpublished data; Waye and Willard, 1986) revealed very
low levels of apparent association, consistent with random
expectation. These signals also frequently localized to a dif-
ferent focal plane of the nucleus than do the SC-35 domains
and their associated genes (Figure 1, A–E) (Xing et al., 1993,
1995). An interesting case is that of collagen 1A1 RNA
(COL1A1), previously shown to consistently associate with
one of the largest SC-35 domains in fibroblast nuclei, a
cell-type in which it is highly expressed (Xing et al., 1995).
Because this gene is also expressed in myoblasts but down-
regulated to low or negligible levels after cells fuse to form
postmitotic skeletal muscle (Beach et al., 1985), it was inter-
esting to determine whether the gene would remain associ-
ated with an SC-35 domains. The myotube nuclei exhibited
RNA foci much smaller in developing muscle fibers than in
fibroblasts. However, these still associated with a prominent
SC-35 domain, consistent with the domain representing a
separate entity. More than 85% of collagen gene signals
remained positioned at the periphery of a prominent do-
main in myotube nuclei, down just slightly from the 99–
100% association seen in fibroblasts (Xing et al., 1995) and
below.
The above-mentioned results demonstrate a specific asso-
ciation of genes with SC-35 domains in muscle fibers, in-
cluding genes that encode both a regulatory factor and more
abundant structural proteins. These results also support that
this spatial localization is locus specific and not a property of
all genes expressing intron-containing RNAs, as discussed
further below.
Are Genes That Localize with SC-35 Domains in Human
Skeletal Muscle Organized in the Same Way within
Human Diploid Fibroblasts?
For those muscle genes that are associated with SC-35 do-
mains, is the association related to cell type and/or expres-
sion of that gene? Because cMyHC and myogenin genes
associated at high frequency with domains in expressing
muscle cells, we addressed whether the same spatial loca-
tion of these genes was observed in other nonexpressing
cell-types, e.g., possibly as a coincidence of chromosomal
localization. To address this, we examined human diploid
Repositioning of Genes in Myogenesis
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Figure 1. Detection of muscle-specific genes or transcripts (red) with SC-35 domains (green) in fully differentiated multinucleated myotubes (A–H) or
in determined but undifferentiated myoblast cells (I, J, and K). (A and C) cMyHC RNA localizes with and frequently fills the interior regions of SC-35
domains. Areas of overlap are yellow. (C) Enlargement of a single cMyHC RNA track and SC-35 domain illustrating overlap (left-most panel). (B and D)
Myogenin RNA associates with and localizes at the SC-35 domain periphery. (D) Enlargement of two domains illustrating specific and consistent
association of myogenin RNA foci at the domain edge. Note the size of the myogenin RNA foci detected are approximately the size of a gene signal as
seen in E and F and are considerably smaller than the domain. (E and F) Occasionally, both alleles of the transcriptionally active myogenin gene associate
with the same SC-35 domain (arrows) in myotube nuclei. (F) The same myotube as in E, stained with DAPI (blue) to delineate multiple nuclei. (G and
H) MyoD RNA (G) and DNA (H) do not associate with prominent SC-35 domains. Inset in G shows an enlarged view of the separation of RNA signal
from the domain. (I–K) Myoblast cells were cropped to show enlargements of all three muscle-specific genes, cMyHC (I), myogenin (J), and MyoD (K), are
not associated with SC-35 domains in myoblast cells before terminal differentiation.
P.T. Moen et al.
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fibroblasts that neither express these genes nor are commit-
ted to do so.
In striking contrast to the gene localization observed in
differentiated muscle, only 13% of cMyHC gene signals and
8% of myogenin gene signals seemed to contact an SC-35
domain in fibroblast cultures. The MyoD gene signal showed
11% association, similar to that seen in myotube nuclei (Fig-
ure 2). Hence, these results support that the cMyHC and
myogenin genes do not associate with domains in this non-
myogenic cell-type, but become specifically positioned at the
domain periphery in nuclei of differentiated muscle. To rule
out that this was due to some global rearrangement of the
nucleus upon muscle differentiation, four other nonmyo-
genic sequences examined in muscle cells were reexamined
here. As shown in Figure 2, none of these showed a change
in their relationship to the SC-35 domains; only the ex-
pressed cMyHC and myogenin genes showed this change in
position. Hence, these results demonstrate that association
of specific genes with domains is cell type dependent, oc-
curring in differentiated cells that express the genes but not
in nonmyogenic cells that do not.
Does Localization with SC-35 Domains Correlate with
Muscle Differentiation or Myoblast Commitment to the
Myoblast Lineage?
At what point in development of specific cell types does the
difference in nuclear gene position between muscle and
fibroblasts arise? Is terminal differentiation necessary or
might the genes become positioned adjacent to an SC-35
domain during commitment to a myoblast lineage, e.g., in
cells determined to form muscle but that have not yet dif-
ferentiated and expressed these genes. To address this, se-
quences were assayed in committed but undifferentiated
satellite myoblasts, still in proliferative phase. Both nonex-
pressed cMyHC and myogenin genes showed very little
(12%) association with SC-35 domains, not significantly
different from random expectation (Figures 1, I and J, and 2).
MyoD, even though expressed early in satellite myoblasts
grown in culture, (Smith et al., 1994; de La Serna et al., 2001a),
did not preferentially associate, in keeping with its localiza-
tion to nondomain space in myotubes (Figure 1K). The fre-
quency of association for the nonmyogenic sequences was
very similar to that in fibroblasts. A summary table of all
results is presented in Figure 2. These results show that these
genes are not prepositioned in myoblasts that are still pro-
liferative and nonexpressing. Hence, developmental com-
mitment to a muscle lineage does not itself result in reposi-
tioning of muscle genes relative to factor rich SC-35
domains.
To further establish a link between splicing factor domain
association and changes in gene expression during muscle
differentiation, we examined the myogenin gene in a differ-
ent model system, using mouse NIH3T3-derived B22 cells
induced to differentiate to muscle by introduction of a ret-
rovirus expressing MyoD. It has been previously docu-
mented that expression of this master muscle regulatory
factor can “convert” nonmuscle cells to a muscle pathway
and induce muscle-specific gene expression, including myo-
genin (Davis et al., 1987; Novitch et al., 1996). As shown
previously for both cMyHC and myogenin (de La Serna et al.,
2001a), introduction of MyoD into the B22 cells converts
them to myoblasts which, when cultured under differentia-
tion-promoting low serum conditions (see MATERIALS
AND METHODS), withdraw from the cell cycle and express
muscle-specific genes (in cells that remain mononucleated).
The expression of muscle markers was confirmed using both
Western blots (our unpublished data) and immunofluores-
cence (Figure 3E). In several experiments the frequency of
cells expressing MyoD or myogenin was typically 70%. In
the mock-infected, nonmuscle cells on average 19% of
mouse myogenin gene loci seemed to contact an SC-35 do-
main (Figure 3, A and B). This is in keeping with a “random”
apparent association, but may be made slightly higher be-
cause the B22 cells tend to have smaller but more numerous
Figure 2. Quantitative analysis of gene organization in
relation to myogenesis. The association of muscle-spe-
cific, nonmuscle, and nonexpressed sequences with
SC-35 domains in differentiated myotubes, determined
myoblasts, and nonmuscle fibroblast cells. Data were
generated from DNA and/or RNA hybridizations. A
sharp increase in association can be seen for cMyHC and
myogenin in differentiated myotubes, concomitant with
expression. No such change in association was seen for
MyoD or for the nonmuscle-specific sequences. The data
generated were gathered from examination of a mini-
mum 50–200 signals, with the exception of albumin in
myotubes where 10 signals were scored and all found to
be nonassociated.
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Figure 3. Localization of muscle specific genes relative to SC-35 domains, centric heterochromatin, and chromosome territories in undifferentiated and
differentiated mouse NIH3T3 (B22) (A–E and H) or human (F and G) fibroblast cells. (A–D) Colors were separated to allow distinct visualization of the
mouse myogenin gene signal (red) with SC-35 domains (green) and DAPI staining of mouse centromeric heterochromatin (blue). (A and B) The mouse
myogenin gene does not associate with domains in undifferentiated cells. (C and D) The mouse myogenin gene in MyoD-induced cells shows a change in
association pattern such that the gene localizes to the edge of SC-35 domains, similar to that seen in human cells. The myogenin gene does not show a
specific relationship to heterochromatin (blue) in either undifferentiated (A and B) or differentiated cells (C and D). The myogenin gene was occasionally
associated with heterochromatin (A, right cell; upper left signal and left signal in D) despite differentiation status but was predominately unassociated. (E)
Myogenin protein staining demonstrating frequency of differentiation (arrow points to one negative cell in a field of six). (F and G) Although certain muscle
specific genes can change their position relative to SC-35 domains upon differentiation, the cMyHC gene localizes at the outer boundaries of its
chromosome paint despite its expression status in both undifferentiated (F) and differentiated human myotubes (G). The peripheral localization was
consistently apparent in two-dimensional images of whole cells. (H) Mouse NIH3T3 cells hybridized with hnRNA (red) by using a probe to Cot-1 DNA
reveal regions of low hnRNA concentration in regions of DAPI-bright (blue) A-T–rich centromeres. A rim of heterochromatin is delineated by the absence
of cot-1 RNA around the nuclear periphery.
P.T. Moen et al.
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SC-35 domains. Interestingly, in B22 cells induced to un-
dergo myogenesis by MyoD, the SC-35 domains became
fewer but larger, as seen in several experiments (supporting
earlier observations in differentiating rat muscle; Lawrence
et al., 1993). Because infection did not result in MyoD expres-
sion in 100% of cells, it was important to identify myogenin-
expressing cells by hybridizing to myogenin nuclear RNA,
which showed that the level of association in these cells was
89% (Figure 3, C and D). This is in keeping with our scoring
of the association level of the myogenin gene in cultures
with a70% infection rate. This fourfold or more increase in
the localization of the myogenin gene with SC-35 domains
was seen in numerous experiments, demonstrating that
MyoD-induced differentiation of B22 cells largely recapitu-
lates the repositioning of this muscle-specific gene adjacent
to SC-35 domains.
Does Association with SC-35 Domains Require
Transcriptional Activation?
We cannot rule out that these genes become “poised” adja-
cent to an SC-35 domain in a small fraction of postmitotic
myoblasts just before their expression. However, results
clearly demonstrate that repositioning of both alleles of
myogenin and cMyHC relative to SC-35 domains typically
occurs concomitant with or very close to initiation of mRNA
expression.
The above-mentioned findings clearly demonstrate that
there is a repositioning of two muscle specific genes relative
to SC-35 domains concomitant with cell type differentiation
and gene expression. The temporal resolution is sufficient to
conclude that gene expression and domain association occur
close in time during muscle differentiation. However, loca-
tion of genes adjacent to an SC-35 domain may occur just
before, at the same time, or just after gene expression begins.
A priori, the most likely possibility may seem to be that
active RNA synthesis and a sufficient level of RNA on the
gene may be a prerequisite for this association to occur.
However, the results mentioned above do not rule out the
possibility that the gene becomes positioned with the do-
main as terminally differentiating cells withdraw from the
cell cycle, but just before gene expression. Hence, the gene
might become “poised” for expression during a narrow
window of time.
Although this is a difficult question to address conclu-
sively, we present initial results that suggest that active gene
expression might not be required and that prepositioning of
the gene before expression remains a viable possibility.
Again, we used the same system as described above in
which NIH3T3 cells are induced by MyoD, but in this case,
we examined the consequences of inducible dominant neg-
ative expression of BRG1, which forms dominant-negative
SWI/SNF, a chromatin remodeling complex that has been
shown necessary for muscle-specific gene expression in
these cells. Expression of the mutant SWI/SNF has been
shown to inhibit expression of myogenin mRNA and protein
to undetectable or negligible levels, while at the same time
allowing withdrawal from the cell cycle (de La Serna et al.,
2001b). We had anticipated that the interference with tran-
scription would prevent any change in location of the myo-
genin gene relative to the SC35 domains after MyoD induc-
tion. Surprisingly, in duplicate experiments there was an
increased association of the myogenin gene with an SC35
domain, significantly above the typical “background” ran-
dom association of15–20% (average 19%) in mock infected
cells (no MyoD). Myogenin gene association with an SC-35
domain in MyoD-infected cultures expressing the mutant
SWI/SNF ranged from 34 to 51%. Because muscle-specific
gene expression is inhibited in these cells, we could not use
the presence of myogenin nuclear RNA foci to distinguish
expressing cells from those that were not infected with
MyoD or not effectively induced to express muscle genes, as
in the above-mentioned experiments with normal SWI/SNF.
Immunofluorescence analysis of parallel cell samples indi-
cated that in these experiments the average MyoD infection
rate was 55–60%, thus the frequency of SC35 association of
34–51% in the total population remains approximate but
likely underrepresents the association rate in cells induced
by MyoD.
Further analyses of this and other genes would need to be
examined to conclude that gene expression is not required
for gene relocalization relative to SC35 domains. However,
these initial findings do indicate that domain association
increases under conditions in which myogenin gene expres-
sion is repressed, although the extent of association may not
be as great as it would otherwise be when RNA synthesis
was more active. These results are sufficient to indicate that
it should not be presumed that significant RNA synthesis is
required. Rather, these results raise the possibility that
MyoD induction of terminal differentiation, in the absence of
significant RNA synthesis, can cause reorganization of cer-
tain muscle-specific genes proximal to factor-rich domains.
In either case, what is most clear is that collectively our
findings show a definitive reorganization of two muscle-
specific genes adjacent to SC35 domains during a short
window of time during which myoblasts differentiate into
muscle, whereas no such nuclear repositioning for several
other sequences occurred.
Does Gene Position Change within the Chromosome
Territory or Relative to Centromeric Heterochromatin?
The above-mentioned results demonstrate that the cMyHC
and myogenin genes become repositioned with cell type
relative to SC-35 domains. We briefly examined positioning
of these genes relative to other features of nuclear topogra-
phy that have been implicated in gene expression, to assess
whether these change concomitantly with SC-35 domain
association. Previous evidence indicates that SC-35 domains
most frequently reside between chromosome territories (Zir-
bel et al., 1993; Clemson and Lawrence, 1996) and that gene
loci may localize specifically at the outer periphery of this
territory. Hence, changes in position relative to the chromo-
some territory and interchromosome space might coinciden-
tally impact position relative to SC-35 domains, or vice
versa. Some evidence indicates that certain active genes
position at the periphery of the territory (Dietzel et al., 1999;
Volpi et al., 2000), whereas analysis of other genes indicates
that they maintain a peripheral position irrespective of ac-
tivity or cell type (Kurz et al., 1996; Dietzel et al., 1999). We
examined the localization of the cMyHC gene relative to its
chromosome 14 territory in both the active state in differen-
tiated myotubes and the inactive state in myoblasts. As
shown in Figure 3, F and G, the gene was clearly and
consistently positioned at the outer boundary of the chro-
mosome 14 territory in both cell types regardless of activity
status. The percentage of cMyHC genes localized at or just
internal to the territory periphery was 81 and 84%, respec-
tively, for myotubes and myoblasts. There was no significant
difference in the small percentage of signals, which seemed
slightly separate from the chromosome territory. This con-
firms prior evidence that muscle genes are peripherally lo-
calized within the chromosome territory in different cell
types (Kurz et al., 1996). Hence, the positioning of the MyHC
gene adjacent to an SC-35 domain is not a consequence of a
repositioning relative to the chromosome territory.
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In recent years, there has been increasing interest in the
idea that inactive genes may be specifically positioned with
respect to centromeric or peripheral heterochromatin and
that close association of certain genes with this heterochro-
matic compartment may causally inactivate their expression
(Brown et al., 1997; Francastel et al., 1999). To examine the
proximity of the myogenin gene to centric heterochromatin,
we took advantage of the fact that the A-T–rich centromeres
of mouse chromosomes are easily visualized with DAPI
staining. That DAPI staining demarcated regions of inactive
heterochromatin was confirmed by hybridization to heter-
ogenous nuclear RNA (hnRNA) by using a probe to Cot-1
DNA, which was previously shown to delimit inactive het-
erochromatin (Hall et al., 2002). Figure 3H demonstrates that
DAPI-bright A-T–rich centromeres occupy regions of low
hnRNA concentration and further illustrates that these cells
have a relatively thin rim of heterochromatin at the nuclear
periphery. The association of the myogenin gene to centro-
meric heterochromatin was examined in expressing and
nonexpressing B22 cultures, by using the model system
described above. In non-MyoD–induced cell cultures in
which no cells express the myogenin gene, 16% of the myo-
genin gene signals seemed associated with the centromeric
heterochromatin (in contact at the periphery) (Figure 3, A
and B). In MyoD-induced cultures, in which most cells ex-
press this gene, the frequency of association with centro-
meric DNA decreased slightly to 14% (Figure 3, C and D).
Frequently, one allele in a nucleus would seem to contact
heterochromatin and the other would not, consistent with a
potentially random relationship (Figure 3D). Infrequently a
gene seemed to contact both an SC-35 domain and centric
heterochromatin simultaneously (Figure 3D). Furthermore,
1% of signals were found to be at the nuclear periphery.
We conclude that the myogenin gene, in 3T3 cells that nor-
mally will never express muscle genes, is not preferentially
positioned in a domain of centric heterochromatin, nor does
its position relative to centric heterochromatin change upon
induction, in contrast to the sharp increase in SC-35 domain
association concomitant with MyoD-induced expression.
These results support that in differentiated cells cMyHC
and myogenin genes reposition specifically with respect to
SC-35 domains and that this localization is not a coincidental
result of global DNA reorganization or changes in gene
position relative to either the chromosome territory or, in
this case, centric heterochromatin. Rather, these results in-
dicate that all regions of the nuclear periphery or the
broader euchromatic nucleoplasm are not equivalent and
that a key parameter that distinguishes different nuclear
regions is proximity to SC-35 domains.
DISCUSSION
This study demonstrates directly that higher level organiza-
tion of specific genes relative to SC-35 domains is cell type
specific and correlates with changes in gene expression dur-
ing differentiation. This demonstration of cell type-specific
gene positioning suggests that spatial organization relative
to factor-rich domains may contribute to gene regulation
during development. Epigenetic changes during develop-
ment permanently impact and coordinate the expression of
tens of thousands of genes. Current concepts of gene regu-
lation focus largely on mechanisms that transiently impact
expression of just one or a few genes. However, mechanisms
that provide heritable, broad-scale genomic regulation may
be more likely to involve stable structural changes to chro-
matin, not only at the level of nucleosome packaging and the
30-nm chromatin fiber, but potentially to the higher order
arrangement of genes or chromosome segments within the
nucleus. At its most basic level the growing recognition that
the nucleus contains numerous “intranuclear compart-
ments” means that the environment of different genes is
different and therefore could influence gene expression;
clearly, a gene’s position adjacent to a large domain enriched
in numerous RNA metabolic factors could reasonably be
expected to facilitate production of its RNA.
Because association with SC-35–rich domains is neither
invariant for a given gene (Xing et al., 1993) nor characteristic
of all genes expressing complex pre-mRNAs (Smith et al.,
1999), it was important to address directly whether associ-
ations seen for a given gene change with cell type-specific
gene expression. Results presented here clearly demonstrate
that the cMyHC and myogenin genes only become associ-
ated with SC-35 domains upon cell type differentiation. In
addition to demonstrating cell type specificity, results here
further strengthen earlier evidence that a substantial fraction
of genes expressing spliced pre-mRNAs associate with
SC-35 domains. In this regard, results for myogenin RNA
are important because this muscle regulatory factor is not so
highly expressed or highly complex as some of the other
pre-mRNAs that have been shown to associate with SC-35
domains, such as cMyHC. Furthermore, the myogenin RNA
focus is far smaller and peripheral to the SC-35 domain with
which it typically associates; it therefore could not have
“formed” the domain, but rather, the gene becomes associ-
ated with a domain of splicing factors that is a separate
entity and likely existed before expression of this gene. As
discussed in detail elsewhere (Smith et al., 1999; Johnson et
al., 2000) several observations support that the domain is not
just comprised of factors bound on an individual pre-
mRNA, but a larger structural conglomerate of numerous
factors with which individual gene loci do or do not associ-
ate.
Consistent with results of uridine incorporation studies
(Fakan and Puvion, 1980; Jackson et al., 1993; Wansink et al.,
1993), our earlier analyses of individual genes showed that
complex pre-mRNAs can be transcribed and spliced by the
less concentrated splicing factors dispersed through the nu-
cleoplasm (Xing et al., 1993; Smith et al., 1999). Comparison
of the myogenin and MyoD results is informative in this
regard, because despite the similarity in complexity and
abundance of these pre-mRNAs, myogenin typically associ-
ates with a discrete SC-35 domain, whereas the MyoD gene
does not. What would account for this difference? As previ-
ously discussed (Smith et al., 1999), we suggest that whether
or not a given type II gene associates with an SC-35 domain
may depend not only on its expression but also on the
presence of specific regulatory elements and/or upon the
constraints of its chromosomal context. Hence, the myoge-
nin gene may be on a region of a chromosome with greater
access to these regions than the MyoD gene. Other studies of
Drosophila nuclei suggest that genes have short-range lateral
mobility, exhibiting “constrained diffusion” within a region
1 m square (Marshall et al., 1997). Where SC-35 domains
initially form is a distinct question, but we suggest this may
be determined by the location of type I genes, such as
cMyHC and COL1A1, whose particularly high demand for
RNA metabolic factors might serve to nucleate a domain;
similarly they might form at sites with a high density of
active genes. Recently, we have found evidence that this
relates to the organization of genes within individual chro-
mosome bands (Shopland et al., 2003). Whatever the mech-
anism that determines where domains form, our results
indicate an intimate, cell differentiation-specific relationship
between specific chromosomal loci and SC-35 domains.
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Whereas cMyHC and myogenin genes changed their spa-
tial association with SC-35 domains concomitant with skel-
etal myogenesis, a parallel change in gene position relative
to the chromosome territory or to centromeric heterochro-
matin was not seen. Consistent with earlier observations
(Kurz et al., 1996), we observed a striking and consistent
localization of the cMyHC gene at the periphery of the
chromosome 14 territory in all cell types studied, irrespec-
tive of activity. Because SC-35 domains typically reside be-
tween chromosome territories, a priori it was possible that
association with domains might coincidentally arise by re-
positioning of the gene to the periphery of the territory. Our
results show that this is not the case, and make the point that
all regions of the chromosome territory periphery are not
equivalent, because only a small part of the periphery con-
tacts an SC-35 domain. Even though both active and inactive
cMyHC genes positioned at the chromosome territory pe-
riphery, it is only the active cMyHC gene that associates with
SC35. It has been reported for the major histocompatibility
gene complex (Volpi et al., 2000) that the locus becomes more
peripheral by the DNA visibly extending or looping out
upon activity. We did not observe such a change here;
however, we cannot rule out that some very subtle change in
extension of the cMyHC gene occurs upon expression.
In our initial analysis of active and inactive genes in the
same cell type (Xing et al., 1995), we noted that inactive
genes localized to heterochromatic regions at the nuclear or
the nucleolar periphery, whereas active genes were with
SC-35 domains (Xing et al., 1995), which themselves avoid
the peripheral heterochromatic region (Carter et al., 1991;
Carter et al., 1993). Because genes localized in a heterochro-
matic region are not associated with SC-35 domains, and
vice versa (Xing et al., 1995), we suggest that these represent
alternative nuclear compartments. However, this work fur-
ther demonstrates an important point: that not all locations
within the broader euchromatic compartment are equiva-
lent, and an inactive gene does not necessarily have to
position with regions concentrated with heterochromatin, as
seen here for the inactive myogenin gene. This is consistent
with very recent evidence that loci differ in their relationship
to heterochromatic domains when inactive (Brown et al.,
2001), analogous to our finding that individual loci differ in
their association with SC-35 domains when active (Xing et
al., 1995; Smith et al., 1999). A recent study of chromosomal
DNA organization relative to these SC-35 domains supports
the idea, further suggested here, that SC-35 domains provide
focal centers for smaller “euchromatic neighborhoods”
within the broader euchromatic compartment of the nucleus
(Shopland et al., 2003). We believe these locus-specific dif-
ferences in nuclear position clearly have functional implica-
tions: the consequent positioning of genes close to domains
rich in RNA metabolic factors may facilitate expression of
the corresponding RNAs, and similarly, positioning away
from these domains may contribute to repression. Although
our findings leave open the possibility that gene positioning
precedes transcriptional activation, an important area of
investigation in the future will be to establish whether the
localization of a gene with domains requires full gene tran-
scription or whether domain association actually contributes
to gene expression by promoting the metabolism of pre-
mRNAs.
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